AHA, others file amicus brief in Maryland to prevent injunction against 340B pricing for contract pharmacy arrangements
The AHA, 340B Health, the Maryland Hospital Association and the Mid-Atlantic Association of Community Health Centers June 26 filed an amicus brief in a federal district court in Maryland, defending the state's law protecting 340B pricing for contract pharmacy arrangements. Similar to a brief filed last week in Mississippi, Novartis Pharmaceuticals is also seeking a preliminary injunction against enforcement of the law in Maryland.
Related News Articles
Headline
The Supreme Court June 28 overturned a 1984 ruling in Chevron U.S.A., Inc. v. Natural Resources Defense Council, Inc., which required courts to defer to…
Headline
The Supreme Court June 27 dismissed a case about whether an Idaho law can coexist with the federal Emergency Medical Treatment and Active Labor Act (EMTALA),…
Headline
The U.S. Court of Appeals for the 5th Circuit June 21 partially affirmed the district court judgment that the Preventative Services Task Force charged with…
Headline
The AHA, along with 340B Health, the Mississippi Hospital Association and the Rural Hospital Alliance filed an amicus brief June 18 in the U.S. District…
Headline
The AHA June 7 submitted comments on a discussion draft of the Drug Shortage Prevention and Mitigation Act, bipartisan legislation proposing to provide…
Headline
The House Energy and Commerce Oversight and Investigations subcommittee June 4 hosted a hearing to discuss oversight of the 340B Drug Pricing Program. AHA sent…